clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Timberlyne Therapeutics Launched Last Week with a $180 Million Series A…
News & Features
New Insights into T-Cell Role in Viral Defense Could Transform Vaccine…
Molecular Dx
Sensitive Tumor DNA Test Effective at Predicting Lung Cancer Progression
Informatics
JPM 2025: NVIDIA, Mayo Clinic Partner on AI-Powered Digital Pathology
News & Features
FDA Clears Solid Biosciences Neurodegeneration Gene Therapy IND
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
FDA Grants Approval for Elacestrant for Patients with ESR1 Mutations in ER+, HER2- Breast Cancers
Nausea
Molecular Dx
FDA Grants Approval for Elacestrant for Patients with ESR1 Mutations in ER+, HER2- Breast Cancers
January 30, 2023
0
Molecular Dx
Pre-Eclampsia Linked to Heart Attack and Stroke Risk
January 26, 2023
0
News & Features
Insilico Medicine’s AI-Designed Fibrosis Drug Passes Phase I Hurdle
January 10, 2023
0
News & Features
Circadian Clock Proteins Point to Potential Drug for Glioblastoma
September 28, 2022
0
Molecular Dx
New Genotype Linked to Nausea and Vomiting during Pregnancy
May 9, 2022
0
News & Features
New Combo Slows Graft Versus Host Disease During Blood Cancer Treatment
December 14, 2021
0
Molecular Dx
Genes Responsible for Extreme Form of Morning Sickness Identified
March 21, 2018
0
Related Content
Sensitive Tumor DNA Test Effective at Predicting Lung Cancer Progression
FDA Clears Solid Biosciences Neurodegeneration Gene Therapy IND
Mayo Clinic, Ambry Genetics Functionally Map 99% of all BRCA2 Hotspot SNVs
Dana-Farber Launches Center for RAS Therapeutics Focused on RAS-Driven Cancers
Inside Precision Medicine